Abstract:Aim: To identify proteins that interact with the C-terminal fragment of annexin A2 (A2IC), generated by plasmin cleavage of the plasmin receptor, a heterotetramer (AA2t) containing annexin A2. Methods: The gene that encodes the A2IC fragment was obtained from PCR-amplified cDNA isolated from human monocytes, and was ligated into the pBTM116 vector using a DNA ligation kit. The resultant plasmid (pBTM116-A2IC) was sequenced with an ABI PRISM 310 Genetic Analyzer. The expression of an A2IC bait protein fused with a LexA-DNA binding domain (BD) was determined using Western blot analysis. The identification of proteins that interact with A2IC and are encoded in a human monocyte cDNA library was performed using yeast two-hybrid screening. The DNA sequences of the relevant cDNAs were determined using an ABI PRISM BigDye terminator cycle sequencing ready reaction kit. Nucleotide sequence databases were searched for homologous sequences using BLAST search analysis ( http://www.ncbi.nlm.nih.gov ). Confirmation of the interaction between the protein LexA-A2IC and each of cathepsin S and SNX17 was conducted using a small-scale yeast transformation and X-gal assay. Results: The yeast transformed with plasmids encoding the bait proteins were screened with a human monocyte cDNA library by reconstituting full-length transcription factors containing the GAL4-active domain (GAL4-AD) as the prey in a yeast two-hybrid approach. After screening 1×10 7 clones, 23 independent β-Gal-positive clones were identified. Sequence analysis and a database search revealed that 15 of these positive clones matched eight different proteins (SNX17, ProCathepsin S, RPS2, ZBTB4, OGDH, CCDC32, PAPD4, and actin which was already known to interact with annexin A2). Conclusion: A2IC A2IC interacts with various proteins to form protein complexes, which may contribute to the molecular mechanism of monocyte activation induced by plasmin. The yeast two-hybrid system is an efficient approach for investigating protein interactions.

Identification of a protein interacting with type 2 methionine aminopeptidase by yeast two-hybrid system

Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis

Study on Proteins Interacting with Angiotensin-(1-7) by Yeast Two-hybrid System

Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies

Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition

MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state

Methionine aminopeptidase 2 and cancer

Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase

Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours

Structural basis for the functional differences between type I and type II human methionine aminopeptidases

S1 pocket fingerprints of human and bacterial methionine aminopeptidases determined using fluorogenic libraries of substrates and phosphorus based inhibitors

Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression

Angiogenesis Inhibitors Specific for Methionine Aminopeptidase 2 As Drugs for Malaria and Leishmaniasis

Methionine aminopeptidases: Potential therapeutic target for microsporidia and other microbes

Yeast Two-Hybrid Screening for Proteins That Interact with Alpha(1)-Adrenergic Receptors

Identification of Interaction Between MEK2 and A-Raf-1.

Identi ¢ cation of interaction between MEK 2 and ARaf-1

Identification of DAT1/LIM2-interacting Proteins by Yeast Two-Hybrid Screening

Yeast Two-Hybrid Screening of Proteins Interacting with Plasmin Receptor Subunit: C-terminal Fragment of Annexin A2.

Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models

Screening of Proteins That Interact with Human Thrombopoietin Receptor C-Mpl Using Yeast Two-Hybrid System